Home > Leads > Defibrillation
6947 Sprint Quattro Secure |
|
|
Product Characteristics |
| US Market Release |
Nov-01 |
|
Serial Number Prefix |
TDG |
| Estimated US Implants |
176,700 |
|
Type and/or Fixation |
Transvenous, Vent, Defib and
Pace/Sense, Screw-in |
| Estimated US Active |
116,400 |
|
Polarity |
True Bipolar/Two Coils |
| Advisories |
None |
|
Steroid |
Yes |
| System Longevity Study Results |
|
| US Returned Product Analysis |
| Implant Damage |
344 |
| Electrical Malfunction |
117 |
| Other |
13 |
|
| Number of Leads Enrolled in Study |
1,367 |
| Cumulative Months of Follow-Up |
51,903 |
| Number of Leads Active in Study |
622 |
| |
|
|
| Qualifying Complications |
19 Total |
|
| Conductor Fracture |
3 |
|
| Failure to Sense |
1 |
|
| Impedance Out of Range |
2 |
|
| Insulation (not further defined) |
1 |
|
| Lead Dislodgement |
3 |
|
| Oversensing |
7 |
|
| Unspecified Clinical Failure |
2 |
|
| |
|
|
| |
|
|
